Galmed Pharmaceuticals Ltd. (GLMD)
Develops drug candidates to treat liver diseases like fatty liver and cirrhosis.
$0.53+0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-65.5%
The outlook
GLMD is trading near its 52-week lows, well below both its 50- and 200-day moving averages, indicating a weak near-term trend. Analyst coverage appears thin, and the overall sentiment leans bearish with a low StockGlow score of 6/100.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range8% of the way from its 52-week low to high
Market cap
$4.1M
52-wk high
$1.93
52-wk low
$0.41
50-day avg
$0.59
200-day avg
$0.78
Trailing P/E
—